[HTML][HTML] Diagnosis and treatment of type 1 diabetes at the dawn of the personalized medicine era
AAS Akil, E Yassin, A Al-Maraghi, E Aliyev… - Journal of translational …, 2021 - Springer
Type 1 diabetes affects millions of people globally and requires careful management to
avoid serious long-term complications, including heart and kidney disease, stroke, and loss …
avoid serious long-term complications, including heart and kidney disease, stroke, and loss …
[HTML][HTML] T cell-mediated beta cell destruction: autoimmunity and alloimmunity in the context of type 1 diabetes
AL Burrack, T Martinov, BT Fife - Frontiers in endocrinology, 2017 - frontiersin.org
Type 1 diabetes (T1D) results from destruction of pancreatic beta cells by T cells of the
immune system. Despite improvements in insulin analogs and continuous blood glucose …
immune system. Despite improvements in insulin analogs and continuous blood glucose …
[HTML][HTML] Patch-seq links single-cell transcriptomes to human islet dysfunction in diabetes
J Camunas-Soler, XQ Dai, Y Hang, A Bautista, J Lyon… - Cell metabolism, 2020 - cell.com
Impaired function of pancreatic islet cells is a major cause of metabolic dysregulation and
disease in humans. Despite this, it remains challenging to directly link physiological …
disease in humans. Despite this, it remains challenging to directly link physiological …
[HTML][HTML] Exosome-derived microRNAs of human milk and their effects on infant health and development
BC Melnik, W Stremmel, R Weiskirchen, SM John… - Biomolecules, 2021 - mdpi.com
Multiple biologically active components of human milk support infant growth, health and
development. Milk provides a wide spectrum of mammary epithelial cell-derived …
development. Milk provides a wide spectrum of mammary epithelial cell-derived …
Emerging routes to the generation of functional β-cells for diabetes mellitus cell therapy
Diabetes mellitus, which affects more than 463 million people globally, is caused by the
autoimmune ablation or functional loss of insulin-producing β-cells, and prevalence is …
autoimmune ablation or functional loss of insulin-producing β-cells, and prevalence is …
[HTML][HTML] Endogenous reprogramming of alpha cells into beta cells, induced by viral gene therapy, reverses autoimmune diabetes
X Xiao, P Guo, C Shiota, T Zhang, GM Coudriet… - Cell stem cell, 2018 - cell.com
Successful strategies for treating type 1 diabetes need to restore the function of pancreatic
beta cells that are destroyed by the immune system and overcome further destruction of …
beta cells that are destroyed by the immune system and overcome further destruction of …
[HTML][HTML] α cell function and gene expression are compromised in type 1 diabetes
Many patients with type 1 diabetes (T1D) have residual β cells producing small amounts of
C-peptide long after disease onset but develop an inadequate glucagon response to …
C-peptide long after disease onset but develop an inadequate glucagon response to …
Cellular and molecular mechanisms coordinating pancreas development
The pancreas is an endoderm-derived glandular organ that participates in the regulation of
systemic glucose metabolism and food digestion through the function of its endocrine and …
systemic glucose metabolism and food digestion through the function of its endocrine and …
The α-cell in diabetes mellitus
J Gromada, P Chabosseau, GA Rutter - Nature Reviews Endocrinology, 2018 - nature.com
Findings from the past 10 years have placed the glucagon-secreting pancreatic α-cell centre
stage in the development of diabetes mellitus, a disease affecting almost one in every ten …
stage in the development of diabetes mellitus, a disease affecting almost one in every ten …
[HTML][HTML] The role of glucagon in the pathophysiology and treatment of type 2 diabetes
Type 2 diabetes is a disease involving both inadequate insulin levels and increased
glucagon levels. While glucagon and insulin work together to achieve optimal plasma …
glucagon levels. While glucagon and insulin work together to achieve optimal plasma …